JFG
IMNM icon

Jefferies Financial Group’s Immunome IMNM Stock Holding History

Jefferies Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,160,715
Closed -$25.4M – 1836
2026
Q1 		$25.4M Sell
1,160,715
-839,285
-42% -$18.7M 0.17% 95
2025
Q4 		$43M Sell
2,000,000
-100,000
-5% -$1.76M 0.22% 86
2025
Q3 		$24.6M Buy
2,100,000
+14,340
+0.7% +$143K 0.12% 128
2025
Q2 		$19.4M Sell
2,085,660
-202,340
-9% -$1.66M 0.16% 104
2025
Q1 		$15.4M Buy
2,288,000
+288,000
+14% +$2.76M 0.14% 98
2024
Q4 		$21.2M Buy
2,000,000
+124,108
+7% +$1.5M 0.13% 121
2024
Q3 		$27.4M Buy
+1,875,892
New +$26.7M 0.2% 66
2024
Q2 		– Sell
-8,740
Closed -$216K – 1615
2024
Q1 		$216K Buy
+8,740
New +$177K ﹤0.01% 1318

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Jefferies Financial Group's IMNM Position: Q2 2026 in Review

Jefferies Financial Group sold out of Immunome (IMNM) in Q2 2026, closing a stake of 1,160,715 shares — an estimated $25.4M sold.

Jefferies Financial Group first reported a position in IMNM in Q1 2024 and held it in 8 quarters. The position peaked at $43M in Q4 2025. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Jefferies Financial Group reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 1,160,715 Immunome shares in Q2 2026, an estimated $25.4M.
  • Jefferies Financial Group first reported a position in Immunome in Q1 2024 and held it in 8 quarters.
  • Jefferies Financial Group's Immunome position peaked at $43M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.